Cutaneous Lupus Erythematosus
Cutaneous Lupus Erythematosus Market

Cutaneous Lupus Erythematosus is a chronic, autoimmune disease that affects the skin, which belongs to the family of lupus erythematosus where the symptoms are confined to the skin. 


Cutaneous Lupus Erythematosus Epidemiological Segmentation 

The Epidemiological Segmentation of Cutaneous Lupus Erythematosus in 7MM from 2017 to 2030 is segmented as:- 

  • Total Prevalent Pool of Cutaneous Lupus Erythematosus
  • Diagnosed Prevalent Pool of Cutaneous Lupus Erythematosus
  • Gender-Specific Prevalent Pool Of Cutaneous Lupus Erythematosus
  • Severity-Specific Prevalent Pool Of Cutaneous Lupus Erythematosus
  • Type-Specific Prevalent Pool of Cutaneous Lupus Erythematosus


Cutaneous Lupus Erythematosus Epidemiology 

  • The total prevalent population of Cutaneous Lupus Erythematosus in 7MM in 2017 was  413,943 
  • Cutaneous Lupus Erythematosus cases in the United States in 2017 was observed to be 240,465 cases  
  • The prevalent cases of Cutaneous Lupus Erythematosus for the males, it was 93,781 cases; on the other hand, for females, it was observed to be 146,684 cases in the United States in 2017.
  • The prevalent cases of Chronic Cutaneous Lupus Erythematosus (CCLE) in the US in 2017 were 187,563 


Cutaneous Lupus Erythematosus Market

The Market Size of Cutaneous Lupus Erythematosus in 7MM in 2017 was USD 559.5 Million  


Cutaneous Lupus Erythematosus Market Drivers

  • Rising Prevalence and Awareness of the disease
  • Refined clinical trial design
  • Contemporary advances in R&D


Cutaneous Lupus Erythematosus Market Barriers

  • Limited translation of therapies into the real world
  • Lack of subtype-specific therapies


Cutaneous Lupus Erythematosus Emerging Drugs

The emerging drugs of the Cutaneous Lupus Erythematosus market are 

  • BIIB059
  • Etanercept
  • Filgotinib
  • GS-9876
  • Delgocitinib
  • VIB7734

And many others. 


Cutaneous Lupus Erythematosus Key Players

The key players in the Cutaneous Lupus Erythematosus market are

  • Biogen
  • Pfizer
  • Galapagos NV /Gilead Sciences
  • LEO Pharma/ Japan Tobacco
  • VIELABIO

 And many others.